Search results
Aug 30, 2023 · Meanwhile, Fosun Pharma has been making rapid progress in its pipeline, with many products successively entered the critical clinical/approval stage. Up to now, the phase III clinical research of ...
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services.
Mar 28, 2023 · In 2022, a subsidiary of Fosun Pharma was licensed under MPP to produce and supply two high-quality and affordable oral COVID-19 drugs to low- and middle-income countries in the globally agreed ...
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare ...
SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis ...
Mar 22, 2022 · Fosun Pharma's 2020 CSR Report issued in March 2021 won a five-star rating (excellent) by China CSR Report Rating Expert Committee. At the same time, Fosun Pharma continued to improve its ESG ...
Jan 9, 2021 · Fosun Pharma is a subsidiary of Fosun Group, the private Chinese conglomerate with vast international holdings that include the Club Med Hotel chain, an English Premier League soccer team, and the ...
